Supreme Court pregabalin hearing to have a big impact on UK pharma patent rights
Next week’s UK Supreme Court hearing on the long-running patent dispute over pregabalin will be watched closely by life sciences innovators.
The final ruling should help clarify the role of ‘plausibility’ in determining the sufficiency of patent…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.